Systemic Sclerosis DIet for GastrointESTinal Symptoms (NCT07402226)
SSc-DIGEST Trial: Systemic Sclerosis DIet for GastrointESTinal Symptoms Randomized Controlled Trial of Low FODMAP, CDED, and NICE Diets for Gastrointestinal Symptoms in Systemic Sclerosis
🩺 Plain-English Summary (8th-Grade Level)
This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of the diets will be available upon contact with the details listed below.
Who can join: Review the eligibility criteria below.
Location: University of Michigan — Ann Arbor, Michigan
Age range: 18 Years
🧪 Interventions in This Study
- Diet 1: Restriction of fermentable carbohydrates (BEHAVIORAL)
- Diet 2: Elimination of foods harmful to gut barrier and microbiome (BEHAVIORAL)
- Diet 3: Regular meal patterns, soluble fiber, and portion control (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Michigan — Ann Arbor, Michigan
📞 Contact the Study Coordinator
Phone: (734) 764-6466
Email: ssc-digest@med.umich.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Systemic Sclerosis (SSc)
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) — La Jolla, California
- Mycophenolate After Stem Cell Transplant for Systemic Sclerosis — Ottawa, Ontario
- Intralesional Injection of STS in Treatment of Calcinosis — Pittsburgh, Pennsylvania
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Phoenix, Arizona
- Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images — New Haven, Connecticut
Explore by condition: All Systemic Sclerosis (SSc) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.